Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 56

Sort by

Sort Order Select

Journal Articles

Enhancing Anti-Tumor Immunity and Responses to Immune Checkpoint Blockade By Suppressing Interleukin-10 in Chronic Lymphocytic Leukemia

Jacqueline R. Rivas, PhDBS, Sara S. Alhakeem, PhD, Joseph M. Eckenrode, PhD, Yinan Zhang, PhD, James P. Collard, BS, Gerhard C. Hildebrandt, MD, Roger A. Fleischman, MD PhD, Li Chen, PhD, Jon S. Thorson, PhD, Markos Leggas, PhD, Subbarao Bondada, PhD

Blood (2019) 134 (Supplement_1): 5486.

https://doi.org/10.1182/blood-2019-127178

Published: 2019

Journal Articles

Congenital STAT3 mutation Mediates Primary Persistent Polymorphic Inflammatory Activation and T Cell Leukemogenesis

Hongxing Liu

Blood (2019) 134 (Supplement_1): 1054.

https://doi.org/10.1182/blood-2019-132138

Published: 2019

Journal Articles

A CD19/CD3 Bispecific Antibody Induces Superior T Cell Responses Against Chronic Lymphocytic Leukemia When Combined with Ibrutinib

Maissa Mhibik, PhD, Erika M Gaglione, Amy Blackburn, Keyvan Keyvanfar, Clare Sun, MD, Inhye E Ahn, MD, Maria Joao Baptista, Junpeng Qi, PhD, Christoph Rader, PhD, Adrian Wiestner, MD PhD

Blood (2019) 134 (Supplement_1): 2861.

https://doi.org/10.1182/blood-2019-126186

Published: 2019

Journal Articles

HLA-Haploidentical Hematopoietic Cell Transplantation after TCR-Αβ and CD45RA+ Depletion Following Reduced Intensity Conditioning in Adults and Children with Hematological Malignancies- Two-Year Follow-up of Multicenter Study in Singapore

Li Mei Poon, MBBS, MRCP, FRCPath, Yeh Ching Linn, MBBS, MRCP, Poh Lin Tan, Ziyi LIM, Balamurugan Vellayappan, Rajat Bhattacharyya, Ah Moy Tan, MD, Lip Kun Tan, MBBS, FRCP, FRCPath, Teck Guan Soh, Colin Phipps Diong, Wing H. Leung, MD PhD, Liang Piu Koh, MBBS, MRCP

Blood (2019) 134 (Supplement_1): 2039.

https://doi.org/10.1182/blood-2019-128014

Published: 2019

Journal Articles

Translational Analysis from CARTITUDE-1, an Ongoing Phase 1b/2 Study of JNJ-4528 BCMA-targeted CAR-T Cell Therapy in Relapsed and/or Refractory Multiple Myeloma (R/R MM), Indicates Preferential Expansion of CD8+ T Cell Central Memory Cell Subset

Enrique Zudaire, PhD, Deepu Madduri, MD, Saad Z. Usmani, MD FACP, Andrzej Jakubowiak, MD PhD, Jesus G. Berdeja, MD, Dong Geng, Syed Rizvi, MD, Tonia Nesheiwat, Jordan M Schecter, MD, Jenna D. Goldberg, MD, Arnob Banerjee, MD, Alicia J. Allred, PhD, Indrajeet Singh, PhD, Raluca Verona, PhD, Ian McCaffery, PhD, Sundar Jagannath

Blood (2019) 134 (Supplement_1): 928.

https://doi.org/10.1182/blood-2019-127309

Published: 2019

Journal Articles

A Simplified Method for Transduction and Expansion of T Cells for Clinical Application

Mariam Khalil, Aaron Foster, PhD, Christine Gagliardi, PhD

Blood (2018) 132 (Supplement 1): 4555.

https://doi.org/10.1182/blood-2018-99-119254

Published: 2018

Journal Articles

Characterization of Allogeneic T Cells Expressing Inducible Caspase-9 Following Adoptive Transfer in Children Receiving an HLA-Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Myeloid Malignancies

Joanne Shaw, PhD, Xiaoou Zhou, MD PhD, An Lu, Valentina Bertaina, Daria Pagliara, MD PhD, Melissa Aldinger, PharmD, David M. Spencer, PhD, Franco Locatelli, Aaron Foster, PhD

Blood (2018) 132 (Supplement 1): 4534.

https://doi.org/10.1182/blood-2018-99-119779

Published: 2018

Journal Articles

Long-Term Treatment with Ibrutinib in Chronic Lymphocytic Leukemia Patients Normalizes CD3 + and CD8 + T Cells and Immune Checkpoints Expression but Gradually Leads to CD4 + T-Cell Depletion

Marzia Palma, MD PhD, Kia Heimersson, Barbro Näsman-Glaser, Håkan Mellstedt, MD PhD, Anders Österborg, MD PhD Prof.

Blood (2017) 130 (Supplement 1): 4322.

https://doi.org/10.1182/blood.V130.Suppl_1.4322.4322

Published: 2017

Journal Articles

Human Double-Degative Regulatory T Cells Modulate Differentiation and Function of Conventional T Cells By Disrupting mTOR Activity

Tabea Haug, Heiko Bruns, PhD, Michael Aigner, PhD, Andreas Mackensen, MD, Simon Voelkl, PhD

Blood (2017) 130 (Supplement 1): 3579.

https://doi.org/10.1182/blood.V130.Suppl_1.3579.3579

Published: 2017

Journal Articles

Imaging Human Immune Cell Infiltration in a Xenograft Graft-Versus-Host Disease Model

Catharina Van Elssen, MD PhD, Mohammad Rashidian, PhD, Vladimir Vrbanac, Christian Freund, Juanjo Cragnolini, Jessica Ingram, PhD, Andrew Tager, Hidde Ploegh, PhD

Blood (2016) 128 (22): 5720.

https://doi.org/10.1182/blood.V128.22.5720.5720

Published: 2016

Journal Articles

Very Early Effects of Ibrutinib on Tumor and Immune Cells in Blood and Lymph Nodes in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Patients

Marzia Palma, MD PhD, Aleksandra Krstic, PhD, Anna Berglöf, PhD, Qing Wang, PhD, Emelie Blomberg, PhD, Stephan Meinke, PhD, Masood Kamali-Moghaddam, PhD, Qiujin Shen, PhD, Georg Jaremko, MD PhD, Jeanette Lundin, MD PhD, Eva Kimby, MD professor, Petter Höglund, MD PhD, Robert Månsson, PhD, Anders Österborg, MD PhD, Edvard Smith, PhD

Blood (2016) 128 (22): 3235.

https://doi.org/10.1182/blood.V128.22.3235.3235

Published: 2016

Journal Articles

Identification of Immune Phenotypes Associated with Improved Progression Free and Overall Survival for Patients with Multiple Myeloma Treated with Autologous Hematopoietic Cell Transplantation

Christine M. Ho, MD, Theresa Hahn, PhD, Paul K. Wallace, MS, PhD, Yali Zhang, Ahmad Fora, MD, George L. Chen, MD, Sarah A. Holstein, MD PhD, Patrick Mellors, Benjamin McCarthy, Sophia R. Balderman, MD, Philip L. McCarthy, MD

Blood (2016) 128 (22): 3454.

https://doi.org/10.1182/blood.V128.22.3454.3454

Published: 2016

Journal Articles

Final Results of a Phase 1/2a, Dose Escalation Study of Pvx-410 Multi-Peptide Cancer Vaccine in Patients with Smoldering Multiple Myeloma (SMM)

Ajay K Nooka, MD MPH, Michael Wang, MD, Andrew J. Yee, MD, Sheeba K. Thomas, MD, Elizabeth K. O'Donnell, MD, Jatin J. Shah, MD, Jonathan L. Kaufman, MD, Doris Peterkin, MBA, Sagar Lonial, MD FACP, Paul G. Richardson, MD, Noopur Raje, MD

Blood (2016) 128 (22): 2124.

https://doi.org/10.1182/blood.V128.22.2124.2124

Published: 2016

Journal Articles

Can Memory T Cell Monitoring Using Flow Cytometry Predict Survival in Haploidentical Hematopoietic Stem Cell Transplantation?

Bohyun Kim, MD PhD, Seongsoo Jang, MD PhD, Yu-Jin Lee, Young-Uk Cho, MD PhD, Chan-Jeoung Park, MD PhD, Eun-Seok Choi, Kyung-Nam Koh, MD PhD, Ho Joon Im, MD PhD, Jong Jin Seo, MD PhD

Blood (2016) 128 (22): 4591.

https://doi.org/10.1182/blood.V128.22.4591.4591

Published: 2016

Journal Articles

T Stem Cell Memory Dynamics during Acute Graft-Versus-Host Disease

Victor Tkachev, PhD, Scott N. Furlan, MD, Ben Watkins, MD, Angela Panoskaltsis-Mortari, PhD, Bruce R. Blazar, MD, Leslie Kean, MD PhD

Blood (2015) 126 (23): 3079.

https://doi.org/10.1182/blood.V126.23.3079.3079

Published: 2015

Journal Articles

Insights into Clonal Relationships of Putative Adaptive Natural Killer Cells (NK) in Humans, Via Mapping of Somatic Piga Mutations in Patients with Paroxysmal Nocturna Hemoglobinuria (PNH)

Thomas Winkler, MD, Marcus A.F. Corat, PhD, Delong Liu, PhD, Moonjung Jung, MD, Danielle M. Townsley, MD, Chuanfeng Wu, PhD, Neal S Young, MD, Cynthia E. Dunbar, MD

Blood (2015) 126 (23): 2223.

https://doi.org/10.1182/blood.V126.23.2223.2223

Published: 2015

Journal Articles

Long-Term Immunological Profile of Patients Treated with Haploidentical HSCT and TK-Cells to Study the Requirements of Memory T Cell Persistence

Giacomo Oliveira, MSc, Maria Teresa Lupo Stanghellini, MD, Eliana Ruggiero, PhD, Nicoletta Cieri, MD PhD, Mattia D'Agostino, MD, Raffaella Greco, MD, Sara Mastaglio, MD, Maddalena Noviello, PhD, Luca Vago, MD PhD, Luca Biasco, PhD, Attilio Bondanza, MD PhD, Alessandro Aiuti, MD, Antonio Lambiase, MD, Manfred Schmidt, PhD, Catia Traversari, PhD, Christof von Kalle, MD, Fabio Ciceri, MD, Claudio Bordignon, MD, Chiara Bonini, MD

Blood (2014) 124 (21): 4793.

https://doi.org/10.1182/blood.V124.21.4793.4793

Published: 2014

Journal Articles

Construction of the Lentiviral and Electric Transfection Vectors Encoding Anti-Human CD30 or CD33 Chimeric Antigen Receptor (CAR) Gene and Respective Expression Injurkat Leukemia Cell Line

Ke Zeng, MD, Ting Niu, MD PhD

Blood (2014) 124 (21): 5950.

https://doi.org/10.1182/blood.V124.21.5950.5950

Published: 2014

Journal Articles

Clinico-Immunobiologic Study By a Prospective Open-Label Clinical Trial of Deferasirox before & after Allogeneic HSCT in Adult Patients with AML - Preliminary Analysis Focusing on Outcomes with Immunocyte Subsets (I) -

Heeje Kim, Jae-Ho Yoon, MD, Seung-Ah Yahng, Sung-Eun Lee, MD, Seung-Hwan Shin, Byung-Sik Cho, Jong-Wook Lee, MD, Woo-Sung Min

Blood (2014) 124 (21): 2543.

https://doi.org/10.1182/blood.V124.21.2543.2543

Published: 2014

Journal Articles

Immune Reconstitution in Recipients of Living Donor Kidney/Hematopoietic Stem + Facilitating Cell Transplants

Joseph R. Leventhal, MD PhD, Mary J Elliott, Esma S. Yolcu, PhD, Larry D. Bozulic, PhD, David J Tollerud, MD MPH, James M Mathew, PhD, Iwona M Konieczna, Michael G Ison, MD, Mark Badder, Michael M I Abecassis, MD MBA, Joshua Miller, MD, Suzanne T. Ildstad, MD

Blood (2014) 124 (21): 191.

https://doi.org/10.1182/blood.V124.21.191.191

Published: 2014

NARROW

Enhancing Anti-Tumor Immunity and Responses to Immune Checkpoint Blockade By Suppressing Interleukin-10 in Chronic Lymphocytic Leukemia

Congenital STAT3 mutation Mediates Primary Persistent Polymorphic Inflammatory Activation and T Cell Leukemogenesis

A CD19/CD3 Bispecific Antibody Induces Superior T Cell Responses Against Chronic Lymphocytic Leukemia When Combined with Ibrutinib

HLA-Haploidentical Hematopoietic Cell Transplantation after TCR-Αβ and CD45RA+ Depletion Following Reduced Intensity Conditioning in Adults and Children with Hematological Malignancies- Two-Year Follow-up of Multicenter Study in Singapore

Translational Analysis from CARTITUDE-1, an Ongoing Phase 1b/2 Study of JNJ-4528 BCMA-targeted CAR-T Cell Therapy in Relapsed and/or Refractory Multiple Myeloma (R/R MM), Indicates Preferential Expansion of CD8+ T Cell Central Memory Cell Subset

A Simplified Method for Transduction and Expansion of T Cells for Clinical Application

Characterization of Allogeneic T Cells Expressing Inducible Caspase-9 Following Adoptive Transfer in Children Receiving an HLA-Haploidentical Hematopoietic Stem Cell Transplant for the Treatment of Myeloid Malignancies

Long-Term Treatment with Ibrutinib in Chronic Lymphocytic Leukemia Patients Normalizes CD3 + and CD8 + T Cells and Immune Checkpoints Expression but Gradually Leads to CD4 + T-Cell Depletion

Human Double-Degative Regulatory T Cells Modulate Differentiation and Function of Conventional T Cells By Disrupting mTOR Activity

Imaging Human Immune Cell Infiltration in a Xenograft Graft-Versus-Host Disease Model

Very Early Effects of Ibrutinib on Tumor and Immune Cells in Blood and Lymph Nodes in Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) Patients

Identification of Immune Phenotypes Associated with Improved Progression Free and Overall Survival for Patients with Multiple Myeloma Treated with Autologous Hematopoietic Cell Transplantation

Final Results of a Phase 1/2a, Dose Escalation Study of Pvx-410 Multi-Peptide Cancer Vaccine in Patients with Smoldering Multiple Myeloma (SMM)

Can Memory T Cell Monitoring Using Flow Cytometry Predict Survival in Haploidentical Hematopoietic Stem Cell Transplantation?

T Stem Cell Memory Dynamics during Acute Graft-Versus-Host Disease

Insights into Clonal Relationships of Putative Adaptive Natural Killer Cells (NK) in Humans, Via Mapping of Somatic Piga Mutations in Patients with Paroxysmal Nocturna Hemoglobinuria (PNH)

Long-Term Immunological Profile of Patients Treated with Haploidentical HSCT and TK-Cells to Study the Requirements of Memory T Cell Persistence

Construction of the Lentiviral and Electric Transfection Vectors Encoding Anti-Human CD30 or CD33 Chimeric Antigen Receptor (CAR) Gene and Respective Expression Injurkat Leukemia Cell Line

Clinico-Immunobiologic Study By a Prospective Open-Label Clinical Trial of Deferasirox before & after Allogeneic HSCT in Adult Patients with AML - Preliminary Analysis Focusing on Outcomes with Immunocyte Subsets (I) -

Immune Reconstitution in Recipients of Living Donor Kidney/Hematopoietic Stem + Facilitating Cell Transplants

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only